Elucid scores $80M for AI imaging analysis software and more digital health fundings
Boston-based medical technology company Elucid, which offers AI-enabled imaging analysis software for cardiovascular disease, announced that it has scored $80 million in Series C funding, bringing its total raise to $121 million.Elevage Medical Technologies…
Continue Reading